This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gozlan, J. Articles by Petit, J. C. Search for Related Content PubMed PubMed Citation Articles by Gozlan, J. Articles by Petit, J. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 09 1996, 2085-2088, Vol 34, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures

J Gozlan, JP Laporte, S Lesage, M Labopin, A Najman, NC Gorin and JC Petit
Department of Virology, Hopital Saint Antoine, Paris, France.

Preemptive therapy is a promising strategy for the prevention of serious cytomegalovirus (CMV) disease after bone marrow (BM) transplantation but requires relevant diagnostic tests. We compared the clinical value of a reverse transcription (RT)-PCR method, which detected a late viral mRNA in peripheral blood leukocytes (PBL), with a PCR method that detected the viral DNA in PBL and with viral culture from leukocytes and urine for the diagnosis of symptomatic CMV infection after BM transplantation. Forty-five consecutive BM recipients were prospectively tested at weekly intervals by the four methods. CMV infection, demonstrated either by the culture of CMV or by repeated detection of viral DNA, was observed in 28 patients, but only 14 developed CMV-related clinical symptoms. The clinical sensitivity and specificity of each technique for detection of symptomatic infection were, respectively, 36 and 74% for urine culture, 43 and 84% for leukocyte culture, 100 and 65% for PCR, and 71 and 94% for RT-PCR. Although PCR detection of DNA in PBL was the earliest and most sensitive technique for the diagnosis of CMV infection, RT-PCR was more predictive of the onset of CMV-related clinical symptoms. These data suggest that both molecular methods should be used for identifying BM recipients at highest risk of CMV disease.

This article has been cited by other articles:

• Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
• Greijer, A. E., Verschuuren, E. A. M., Harmsen, M. C., Dekkers, C. A. J., Adriaanse, H. M. A., The, T. H., Middeldorp, J. M. (2001). Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 39: 251-259 [Abstract] [Full Text]  
• Blok, M. J., Lautenschlager, I., Goossens, V. J., Middeldorp, J. M., Vink, C., Höckerstedt, K., Bruggeman, C. A. (2000). Diagnostic Implications of Human Cytomegalovirus Immediate Early-1 and pp67 mRNA Detection in Whole-Blood Samples from Liver Transplant Patients Using Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 38: 4485-4491 [Abstract] [Full Text]  
• Gerna, G., Percivalle, E., Baldanti, F., Sozzani, S., Lanzarini, P., Genini, E., Lilleri, D., Revello, M. G. (2000). Human Cytomegalovirus Replicates Abortively in Polymorphonuclear Leukocytes after Transfer from Infected Endothelial Cells via Transient Microfusion Events. J. Virol. 74: 5629-5638 [Abstract] [Full Text]  
• Gerna, G., Baldanti, F., Lilleri, D., Parea, M., Alessandrino, E., Pagani, A., Locatelli, F., Middeldorp, J., Revello, M. G. (2000). Human Cytomegalovirus Immediate-Early mRNA Detection by Nucleic Acid Sequence-Based Amplification as a New Parameter for Preemptive Therapy in Bone Marrow Transplant Recipients. J. Clin. Microbiol. 38: 1845-1853 [Abstract] [Full Text]  
• Blank, B. S. N., Meenhorst, P. L., Mulder, J. W., Weverling, G. J., Putter, H., Pauw, W., van Dijk, W. C., Smits, P., Lie-A-Ling, S., Reiss, P., Lange, J. M. A. (2000). Value of Different Assays for Detection of Human Cytomegalovirus (HCMV) in Predicting the Development of HCMV Disease in Human Immunodeficiency Virus-Infected Patients. J. Clin. Microbiol. 38: 563-569 [Abstract] [Full Text]  
• Davoli, E. H., Lipson, S. M., Match, M. E., Shepp, D. H., Morin, J. W., Curley, D. M. (1999). Evaluation of the PrimeCapture CMV DNA Detection Plate System for Detection of Cytomegalovirus in Clinical Specimens. J. Clin. Microbiol. 37: 2587-2591 [Abstract] [Full Text]  
• Gerna, G., Baldanti, F., Middeldorp, J. M., Furione, M., Zavattoni, M., Lilleri, D., Revello, M. G. (1999). Clinical Significance of Expression of Human Cytomegalovirus pp67 Late Transcript in Heart, Lung, and Bone Marrow Transplant Recipients as Determined by Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 37: 902-911 [Abstract] [Full Text]  
• Greijer, A. E., van de Crommert, J. M. G., Stevens, S. J. C., Middeldorp, J. M. (1999). Molecular Fine-Specificity Analysis of Antibody Responses to Human Cytomegalovirus and Design of Novel Synthetic-Peptide-Based Serodiagnostic Assays. J. Clin. Microbiol. 37: 179-188 [Abstract] [Full Text]  
• Tong, C. Y. W., Cuevas, L., Williams, H., Bakran, A. (1998). Use of Laboratory Assays To Predict Cytomegalovirus Disease in Renal Transplant Recipients. J. Clin. Microbiol. 36: 2681-2685 [Abstract] [Full Text]  
• Blok, M. J., Goossens, V. J., Vanherle, S. J. V., Top, B., Tacken, N., Middeldorp, J. M., Christiaans, M. H. L., van Hooff, J. P., Bruggeman, C. A. (1998). Diagnostic Value of Monitoring Human Cytomegalovirus Late pp67 mRNA Expression in Renal-Allograft Recipients by Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 36: 1341-1346 [Abstract] [Full Text]